Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-19 Purchase | 2026-02-23 07:49 am | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 150,000 | $1.465 | $219,755 | 51,558,909 (Indirect Direct) | View |
| 2026-02-13 Purchase | 2026-02-18 4:30 pm | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 268,497 | $1.3143 | $352,889 | 51,408,909 (Indirect Direct) | View |
| 2026-02-02 Purchase | 2026-02-04 4:25 pm | LEXICON PHARMACEUTICALS INC. | LXRX | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 1,538,462 | $1.3 | $2,000,001 | 42,606,727 (Indirect) | View |
| 2024-12-10 Sale | 2024-12-12 4:39 pm | Scholar Rock Holding Corp | SRRK | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 1,600,000 | $41.65 | $66,640,000 | 9,250,005 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 4:31 pm | Scholar Rock Holding Corp | SRRK | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 409,433 | $38.49 | $15,757,639 | 10,850,005 (Direct) | View |
| 2024-08-07 Sale | 2024-08-09 4:30 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 322,361 | $0.18987 | $61,206 | 6,317,565 (Direct) | View |
| 2024-08-05 Sale | 2024-08-07 4:30 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 220,255 | $0.18698 | $41,184 | 6,639,926 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 4:53 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 349,764 | $0.20327 | $71,097 | 6,860,181 (Direct) | View |
| 2024-07-26 Sale | 2024-07-30 5:16 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 1,379,119 | $0.2286 | $315,262 | 7,209,945 (Direct) | View |
| 2023-10-10 Purchase | 2023-10-12 4:01 pm | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 1,000,000 | $1.104 | $1,103,957 | 6,792,051 (Indirect Direct) | View |
| 2022-11-10 Purchase | 2022-11-15 5:26 pm | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 75,000 | $4.2674 | $320,055 | 126,432 (Direct) | View |
| 2022-08-05 Purchase | 2022-08-09 4:48 pm | LEXICON PHARMACEUTICALS INC. | LXRX | Invus US Partners LLC Ulys L.L.C. DEBBANE RAYMOND Director 10% Owner | 147,390 | $2.5 | $368,475 | 5,782,749 (Indirect Direct) | View |
| 2022-08-01 Purchase | 2022-08-01 4:15 pm | LEXICON PHARMACEUTICALS INC. | LXRX | Invus US Partners LLC Ulys L.L.C. DEBBANE RAYMOND Director 10% Owner | 982,600 | $2.5 | $2,456,500 | 5,635,359 (Indirect Direct) | View |
| 2022-08-01 Purchase | 2022-08-01 4:13 pm | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 982,600 | $2.5 | $2,456,500 | 5,635,359 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-11 Exercise | 2026-02-06 5:35 pm | 2022-06-22 2025-12-31 | Scholar Rock Holding Corp | SRRK | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND 10% Owner | 1,575,008 | $0 | 10,825,013 (Direct) | View |
| 2025-12-11 Exercise | 2026-02-06 5:35 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND 10% Owner | 1,575,008 | $7.35 | 10,825,013 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:25 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 367,145 | $65 | 42,606,727 (Indirect) | View |
| 2026-02-02 Option Award | 2026-02-04 4:25 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 22,400,000 | $1.3 | 42,606,727 (Indirect) | View |
| 2025-06-03 Option Award | 2025-06-03 4:20 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-13 5:48 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 36,810 | $0 | 45,755,796 (Direct) | View |
Ownership | 2024-07-29 6:03 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 0 | $0 | 12,834,446 (Direct) | View |
Ownership | 2024-07-29 5:55 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 0 | $0 | 8,589,064 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-13 4:02 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-04-28 Exercise | 2024-04-29 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 8,032 | $0 | 6,800,083 (Direct) | View |
| 2023-05-21 Exercise | 2023-05-22 4:03 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 9,302 | $0 | 5,792,051 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:12 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Former Director Director | 835 | $0 | 134,387 (Direct) | View |
| 2023-04-28 Option Award | 2023-04-28 4:22 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 20,690 | $0 | 20,690 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-05 4:05 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 2,053 | $0 | 133,552 (Direct) | View |
| 2023-01-02 Option Award | 2023-01-04 4:22 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 5,067 | $0 | 131,499 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 5:27 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 4,595 | $0 | 51,432 (Direct) | View |
| 2022-07-04 Option Award | 2022-07-06 4:31 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 2,745 | $0 | 46,837 (Direct) | View |
| 2022-05-21 Option Award | 2022-05-23 4:14 pm | N/A 2032-05-21 | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 23,704 | $0 | 23,704 (Direct) | View |
| 2022-04-30 Exercise | 2022-05-02 4:14 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 4,024 | $0 | 4,652,759 (Direct) | View |
| 2022-04-04 Option Award | 2022-04-06 4:15 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 1,797 | $0 | 44,092 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:16 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 1,179 | $15.9 | 42,295 (Direct) | View |
| 2021-10-04 Option Award | 2021-10-06 4:07 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 998 | $18.78 | 41,116 (Direct) | View |
| 2021-07-05 Option Award | 2021-07-07 4:20 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 523 | $35.84 | 40,118 (Direct) | View |
| 2021-04-30 Option Award | 2021-05-03 5:03 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 10,499 | $0 | 10,499 (Direct) | View |
| 2021-04-24 Exercise | 2021-04-27 4:47 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 10,638 | $0 | 4,648,735 (Direct) | View |
| 2021-04-05 Option Award | 2021-04-07 4:17 pm | N/A N/A | WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director | 609 | $30.77 | 39,595 (Direct) | View |